Victor Velásquez-Rimachi

Victor Velásquez-Rimachi

Auto-generated profile, based on publicly available information

Victor Velásquez-Rimachi

Grupo de Investigación en Healthcare Simulation & Medical Education (HeSIM), Facultad de Ciencias de la Salud, Universidad Científica del Sur. Lima, Perú

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2021 in Epilepsia
Verified
Journal Article
Closed access
PDF file
CACarlos Alva-Diaz
Carlos Alva-Diaz
ANAlba Navarro-Flores
Alba Navarro-Flores
OROscar Rivera‐Torrejon
Oscar Rivera‐Torrejon
AHAndrely Huerta‐Rosario
Andrely Huerta‐Rosario
RMRoberto A. Molina
Roberto A. Molina
KPKevin Pacheco-Barrios
Kevin Pacheco-Barrios

21 June 2022 in Acta Neurologica Scandinavica
Verified
Journal Article
Closed access
VVVictor Velásquez‐Rimachi
Victor Velásquez‐Rimachi
JCJorge Chachaima‐Mar
Jorge Chachaima‐Mar
ECElena Cristina Cárdenas‐Baltazar
Elena Cristina Cárdenas‐Baltazar
ALAlejandra Loayza‐Vidalon
Alejandra Loayza‐Vidalon
CMCristian Morán
Cristian Morán
CACarlos Alva-Diaz
Carlos Alva-Diaz

25 June 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MCMiguel Cabanillas-Lazo
Miguel Cabanillas-Lazo
CQCarlos Quispe-Vicuña
Carlos Quispe-Vicuña
MPMilagros Pascual-Guevara
Milagros Pascual-Guevara
CCClaudia Cruzalegui-Bazán
Claudia Cruzalegui-Bazán
ADArturo Duran-Pecho
Arturo Duran-Pecho
VVVictor Velásquez-Rimachi
Victor Velásquez-Rimachi
Introduction: Insulin resistance (IR) is a common metabolic disorder associated with obesity, type 2 diabetes, and cardiovascular diseases. There is a need for simpler and more cost-effective indices to diagnose IR in pediatric populations. While the hyperinsulinemic-euglycemic clamp is the gold standard for diagnosing IR, it is costly and complex. Consequently, simpler indices like the triglyceride-to-glucose (TyG) and triglyceride/high-density lipoprotein (Tg/HDL) indices have been explored as alternative diagnostic tools for IR. Methods: This systematic review adhered to PRISMA-DTA guidelines. Analytical studies evaluating the diagnostic accuracy of TyG and Tg/HDL indices for IR in children and adolescents were included. Eligibility criteria required studies to report sensitivity, specificity, or area under the curve (AUC) values compared against reference standards for IR. Excluded studies were those without reported diagnostic accuracy measures. Data were extracted from PubMed, Scopus, Web of Science, Embase, and SciELO Citation Index up to April 2024. Due to high heterogeneity, a narrative synthesis was performed. Results: Twenty-one studies involving 28,768 participants were included. The TyG index showed sensitivities ranging from 60–92% and specificities of 54–100%, with AUCs between 0.610 and 0.960. For the Tg/HDL index, sensitivities varied from 14.8–85.7%, specificities from 60.9–97.6%, and AUCs from 0.687 to 0.809. These results suggest that the TyG index generally demonstrates higher diagnostic precision than the Tg/HDL index, but both exhibit moderate accuracy with considerable heterogeneity. Conclusion: The TyG and Tg/HDL indices are promising tools for diagnosing IR in children and adolescents, but further studies with rigorous methodology are needed. Future research should focus on standardizing cut-off points and exploring their predictive value in diverse populations.

1 January 2020 in Neurología Argentina
Verified
Journal Article
Closed access
CACarlos Alva-Diaz
Carlos Alva-Diaz
NMNicanor Mori
Nicanor Mori
KPKevin Pacheco-Barrios
Kevin Pacheco-Barrios
VVVictor Velásquez-Rimachi
Victor Velásquez-Rimachi
OROscar Rivera-Torrejon
Oscar Rivera-Torrejon
PMPilar Elena Mazzetti-Soler
Pilar Elena Mazzetti-Soler

19 June 2020 in Journal of Public Health
Verified
Journal Article
Closed access
PDF file
CACarlos Alva-Diaz
Carlos Alva-Diaz
AHAndrely Huerta-Rosario
Andrely Huerta-Rosario
RMRoberto A. Molina
Roberto A. Molina
KPKevin Pacheco-Barrios
Kevin Pacheco-Barrios
WAWilfor Aguirre-Quispe
Wilfor Aguirre-Quispe
RSRoberto Romero Sanchez
Roberto Romero Sanchez

1 June 2022 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
MMMarco Malaga
Marco Malaga
ARAaron Rodriguez-Calienes
Aaron Rodriguez-Calienes
VVVictor Velasquez-Rimachi
Victor Velasquez-Rimachi
CACarlos Alva-Diaz
Carlos Alva-Diaz
Background: Guillain-Barré syndrome (GBS) is an autoimmune disease of the peripheral nervous system that caused multiple epidemiological outbreaks in Peru during 2018 and 2019. It is usually diagnosed using the Brighton criteria (BC). Objective: We aimed to determine the performance of Peruvian neurologists in diagnosing GBS based on the BC, along with its associated factors. Methods: This was a retrospective multicenter cohort study. We included patients diagnosed with GBS between 2007 and 2018 in three public hospitals in Lima, Peru. We collected data regarding demographic, clinical and management characteristics. We evaluated the use of the BC for confirmatory diagnosis of GBS and developed a logistic regression model to identify factors associated with its use. Results: Out of 328 cases, we reviewed 201 available charts. The median age was 48 years, with male predominance. Over half of the patients presented an inadequate motor examination according to their Medical Research Council (MRC) score. Additional testing included lumbar puncture and electrophysiological testing, in over 70% of the cases. The BC showed certainty level 1 in 13.4% and levels 2 and 3 in 18.3%. Neither the quality of the motor examination nor the type of institution showed any association with the BC. Conclusions: Level 1 diagnostic certainty of the BC was met in less than one quarter of the cases with a GBS diagnosis in three centers in Lima, Peru, between 2007 and 2018. This level was not significantly associated with being treated in a specialized institute, rather than in a general hospital.